Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Dr Lauren Macdonald (UK), Dr Ted Cassidy & Peter Hunt AM

Topic: Psychedelic-Assisted Therapy: Q&A for Clinicians

There are only a matter of weeks to go until MDMA & psilocybin-assisted therapies become available in Australia outside of clinical trials. Clinicians are filled with questions, as they wonder how things will progress once July 1st comes.

And so we would like to invite students and graduates of our CPAT program and other clinicians to join us for this important Q&A session. It will be illuminating and clarifying for all.

In this session, we will cover:

1. What’s going to happen from July?

Co-founder of Monarch Mental Health Dr Ted Cassidy & Chair of MMA Peter Hunt AM will answer questions from community members such as:

How does the authorised prescriber process work?
What will the roll out look like at a clinic actively offering PAT?
What do doctors interested in supporting PAT need to know?
What options exist for non-psychiatrists wanting to get started working with PAT?

2. How to develop as a skillful, safe and ethical psychedelic-assisted therapist

Dr Lauren Macdonald from Imperial College London will share her perspective on the experience of working clinically with psychedelics. You’ll learn:

What does one need to consider to develop as a skillful, safe and ethical psychedelic-assisted therapist?
What are some of the biggest challenges for clinicians entering this space to consider?
What advice would you give to clinicians before their first dosing session?

Due to the nature of this presentation, ONLY verified clinicians will be admitted into the session.You will be asked to enter details to confirm your occupation on registering for the webinar.

We’ll be accepting questions before and during the webinar. You’ll find a link to submit questions in your confirmation email.

Date: Tuesday 6 June 2023

Time: 6:25pm for 6:30pm start – 7:45pm (incl Q&A) (AEST)

The presentation WILL BEGIN AT 6:30pm.

Location: Online. A link will be emailed to you with the viewing details

Don’t miss out - Get your tickets early!

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

More about the presenters

Dr Lauren Macdonald (UK)

Clinical Research Fellow at Imperial College London and co-founder of Essence Medicine

Lauren Macdonald is a psychiatry doctor, group facilitator and co-founder of Essence Medicine, an organisation providing
psycho-spiritual care to people facing life threatening illness. As a clinical trial doctor and therapist at the Centre for Psychedelic
Research, Imperial College London, she works across several psychedelic trials, mainly with psilocybin and DMT. Lauren is particularly
passionate about weaving psycho-spiritual care, including psychedelic-assisted therapy, into modern healthcare, especially within
the palliative care setting. She has degrees in Medicine and Psychology, and has undertaken further certificates in Integrative Medicine,
Compassionate Inquiry, Yoga and Psychedelic-Assisted Therapy (Multidisciplinary Association for Psychedelic Studies). She is a
student of ancient wisdom traditions and an advocate for sacred reciprocity.

Dr Ted Cassidy

Psychiatrist & Co-founder of Monarch Mental Health Group

Dr Ted Cassidy is Co-founder of Monarch Mental Health Group. He has been delivering innovative mental health treatment services for over 20 years, including TMS.

Dr Cassidy has worked extensively since 2014 in the field of developing next-step mental health treatments for patients with depression, anxiety and related mental health conditions. Dr Cassidy previously founded and owned The Hills Clinic group and hospital, the first purpose built private mental health hospital in Australia. From 2004 to 2017 he was the Medical Director, during this time more than 10,000 patients with Mental Illness were assisted in the Northwest of Sydney.

Peter Hunt AM

Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years. He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world. He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia. He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Support psychedelic research and therapy development

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.